Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.240
-0.089 (-6.70%)
At close: Apr 24, 2025, 4:00 PM
1.140
-0.100 (-8.06%)
Pre-market: Apr 25, 2025, 6:17 AM EDT
Mustang Bio Employees
Mustang Bio had 6 employees as of December 31, 2024. The number of employees decreased by 74 or -92.50% compared to the previous year.
Employees
6
Change (1Y)
-74
Growth (1Y)
-92.50%
Revenue / Employee
n/a
Profits / Employee
-$2,625,333
Market Cap
4.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
MBIO News
- 7 weeks ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 2 months ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 3 months ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire
- 5 months ago - Mustang Bio Receives Positive Listing Determination from Nasdaq - GlobeNewsWire
- 6 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - GlobeNewsWire